🇺🇸 FDA
Pipeline program

Autologous Volar Fibroblast Injection into the Terminal Limb of Amputees

W81XWH1820055

Phase 2 other active

Quick answer

Autologous Volar Fibroblast Injection into the Terminal Limb of Amputees for Amputation is a Phase 2 program (other) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Amputation
Phase
Phase 2
Modality
other
Status
active

Clinical trials